Long-term efficacy of recombinant human growth hormone therapy in short-statured patients with Noonan syndrome

PURPOSE: Noonan syndrome (NS) is characterized by short stature, heart anomalies, developmental delays, dysmorphic features, cryptorchidism, and coagulation defects. Several studies reported the short-term effects of recombinant human growth hormone (rhGH) treatment on the improvement of height. Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeong, Insook, Kang, Eungu, Cho, Ja Hyang, Kim, Gu-Hwan, Lee, Beom Hee, Choi, Jin-Ho, Yoo, Han-Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pediatric Endocrinology 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835558/
https://www.ncbi.nlm.nih.gov/pubmed/27104176
http://dx.doi.org/10.6065/apem.2016.21.1.26

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835558/
https://www.ncbi.nlm.nih.gov/pubmed/27104176
http://dx.doi.org/10.6065/apem.2016.21.1.26

Ejemplares similares